loading
Papers Papers/2022 Papers Papers/2022

Research.Publish.Connect.

Paper

Authors: Thomas Ostermann 1 ; Sebastian Appelbaum 1 ; 2 ; Stephan Baumgartner 3 ; Lukas Rist 4 and Daniel Krüerke 4 ; 3

Affiliations: 1 Methods and Statistics in Psychology, Faculty of Health, Witten/Herdecke University, Witten, Germany ; 2 Trimberg Research Academy, University of Bamberg, Bamberg, Germany ; 3 Society for Cancer Research, Hiscia Institute, Arlesheim, Switzerland ; 4 Clinic Arlesheim, Research Department, Arlesheim, Switzerland

Keyword(s): Survival Analysis, Clinical Registry, Cancer, Integrative Oncology.

Abstract: Survival analysis is the basis for research into all types of treatments aimed at prolonging the overall survival of a cancer entity. Before we use data from a cancer registry at the Clinic Arlesheim (CRCA) for more sophisticated survival analysis in relation to integrative oncology treatments, we wanted to learn more about the possible differences between the clientele in this database and the public. In a first step we compared survival rates for breast cancer and pancreatic cancer analyzed from CRCA-data with the cor-responding survival rate (all stages) available at the Robert-Koch-Institute. Furthermore, we differentiated the survival rates from CRCA-patients with respect to the fraction of the survival time in the care of the clinic Arlesheim. While the survival rates of CRCA-patients with breast cancer or with pancreatic cancer show similar survival rates compared to corresponding data from the Robert-Koch-Institute, the sensitivity analysis suggests that the longer the fracti on of the survival time in the care of the clinic Arlesheim the higher the expected survival rates. In conclusion, the analysis and comparison of the survival rates of a clinical population of a cancer registry, such as CRCA, may lead to a better identification of responders and non-responders and thus in the long run may help to optimise integrative and patient cantered treatment strategies. (More)

CC BY-NC-ND 4.0

Sign In Guest: Register as new SciTePress user now for free.

Sign In SciTePress user: please login.

PDF ImageMy Papers

You are not signed in, therefore limits apply to your IP address 54.144.233.198

In the current month:
Recent papers: 100 available of 100 total
2+ years older papers: 200 available of 200 total

Paper citation in several formats:
Ostermann, T.; Appelbaum, S.; Baumgartner, S.; Rist, L. and Krüerke, D. (2022). Using Merged Cancer Registry Data for Survival Analysis in Patients Treated with Integrative Oncology: Conceptual Framework and First Results of a Feasibility Study. In Proceedings of the 15th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2022) - HEALTHINF; ISBN 978-989-758-552-4; ISSN 2184-4305, SciTePress, pages 463-468. DOI: 10.5220/0010826400003123

@conference{healthinf22,
author={Thomas Ostermann. and Sebastian Appelbaum. and Stephan Baumgartner. and Lukas Rist. and Daniel Krüerke.},
title={Using Merged Cancer Registry Data for Survival Analysis in Patients Treated with Integrative Oncology: Conceptual Framework and First Results of a Feasibility Study},
booktitle={Proceedings of the 15th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2022) - HEALTHINF},
year={2022},
pages={463-468},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0010826400003123},
isbn={978-989-758-552-4},
issn={2184-4305},
}

TY - CONF

JO - Proceedings of the 15th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2022) - HEALTHINF
TI - Using Merged Cancer Registry Data for Survival Analysis in Patients Treated with Integrative Oncology: Conceptual Framework and First Results of a Feasibility Study
SN - 978-989-758-552-4
IS - 2184-4305
AU - Ostermann, T.
AU - Appelbaum, S.
AU - Baumgartner, S.
AU - Rist, L.
AU - Krüerke, D.
PY - 2022
SP - 463
EP - 468
DO - 10.5220/0010826400003123
PB - SciTePress